Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
Follow-Up Questions
ACRO Biomedical Co Ltd의 CEO는 누구입니까?
Mr. Pao-Chi Chu은 2017부터 회사에 합류한 ACRO Biomedical Co Ltd의 President입니다.
ACBM 주식의 가격 성능은 어떻습니까?
ACBM의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
ACRO Biomedical Co Ltd의 주요 사업 주제나 업종은 무엇입니까?
ACRO Biomedical Co Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
